COVID-19: Lopinavir-ritonavir failed
Following unblinding of the efficacy study, the principal investigators of the RECOVERY trial concluded that there is no beneficial effect of the...
COVID 19: Halix ready for vaccine production
Dutch CDMO HALIX B.V. has joined a research consortium coordinated by the University of Oxford, to provide GMP-compliant production of Vaccitech...
Hyloris Pharmaceuticals prepared to go public
Reformulation specialist Hyloris Pharmaceuticals SA wants to go public on the regulated market of Euronext Brussels. The company reformulates...
Making opoids more effective pain killers
The m-opioid receptor (MOR) is an important target for pain management and can be activated by natural opioids, like morphine, and synthetic opioids,...
Carbios SAS publishes PET recycling technology
Polyethylenterephtalat (PET) waste makes one fifth of the 359 million tons of mostly non-degradable plastics produced annually. Once used, the...
GE renamed Cytiva upon take-over by Danaher
The acquisition of GE Healthcare Life Sciences by Danaher Corporation creates a giant in contract manufacturing and development. While GE Healthcare...
Drug from worms dampens autoimmune response
According to researchers headed by Julia Esser-von Bieren from Helmholtz Center Munich, Germany, the products from parasitic helminths might help...